Skip to main content

Advertisement

Log in

Polypill as a Personalized Dosage Form: Production Technology (Review)

  • DRUG SYNTHESIS METHODS AND MANUFACTURING TECHNOLOGY
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Modern technologies for production of polypills used as a dosage form for personalized therapy are reviewed. Polypills can be in the form of multi-layer tablets or multi-particulate formulations [capsule with tablets, mini-tablets (micro-tablets), pellets (granules), powder]. Modern technologies for production of multi-layered tablets and multi-particulate formulations, dosing systems, and packaging developed for polypills are considered in detail. Polypills address the important issues of multidrug therapy such as physicochemical or pharmacological incompatibility of the components by separation of active pharmaceutical ingredients, controlled release, and personalization of the dosage form through reconfiguration and ensure patient adherence to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

References

  1. S. C. Finch, Pat. WIPO (PCT) WO-2021136948-A1, Jul. 8, 2021; National Center for Biotechnology Information (2022).

  2. K. Teo and S. Yusuf, Am. J. Hypertens., 31(7), 758 – 761 (2018).

    Article  CAS  PubMed  Google Scholar 

  3. N. J. Wald and M. R. Law, Br. Med. J., 326(7404), 1419 (2003).

    Article  CAS  Google Scholar 

  4. A. N. Parkhomenko, in: Abstracts of Papers of the XVIIIth National Congress of Cardiologists of Ukraine [in Russian], Kiev (2017).

  5. S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebel’nyi, et al., Ratsion. Farmakoter. Kardiol., 13(3), 323 – 329 (2017).

  6. D.-W. Kim and K. Y. Weon, J. Pharm. Invest., 51(2), 555 – 570 (2021).

    Article  CAS  Google Scholar 

  7. M. Janczura, S. Sip, and J. Cielecka-Piontek, Pharmaceutics, 14(4), 834 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. E. Menditto, V. Orlando, G. De Rosa, et al., Pharmaceutics, 12(1), 44 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. K. Moodley, V. Pillay, Y. E. Choonara, et al., Int. J. Mol. Sci., 13(1), 18 – 43 (2012).

    Article  CAS  PubMed  Google Scholar 

  10. Triple Layer and Core Tablet, https: //www.ptk-gb.com/research-and-development-tablet-press/PR-LT-Laboratory-tabletpress/

  11. K. S. Seo, R. Bajracharya, S. H. Lee, et al., Pharmaceutics, 12(9), 853 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. M. W. Wilson, L. Martini, and A. Clarke, Developing Drug Products in an Aging Society, Vol. 26, Springer, Cham (2016).

    Google Scholar 

  13. E. K. Bhatia, P. Vaishy, A. Mishra, et al., Int. J. Pharm. Biol. Arch., 5(4), 9 – 18 (2014).

    Google Scholar 

  14. M.-H. Chun, J. Y. Kim, E.-S. Park, and D. H. Choi, Pharmaceutics, 13(9), 1443 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. D. H. Won, H. Park, E. S. Ha, et al., Int. J. Pharm., 605 (2021).

  16. V. Demiri, S. Stranzinger, P. Rinner, et al., Int. J. Pharm., 548(1), 672 – 681 (2018).

    Article  CAS  PubMed  Google Scholar 

  17. J. U. Song, G. T. Kim, et al., RU Pat. 2,663,460 C2, Aug. 6, 2018; https: //rusneb.ru/catalog/000224_000128_0002663460_20180806_C2_RU/.

  18. K. S. Seo and H. K. Han, Pharmaceutics, 11(7), 313 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. N. Shahid, S. Adnan, M. Farooq, et al., Acta Pol. Pharm., 74(2), 477 – 487 (2017).

    CAS  PubMed  Google Scholar 

  20. G. P. Andrews, S. Li, A. Almajaan, et al., Mol. Pharmaceutics, 16(5), 1827 – 1838 (2019).

    Article  CAS  Google Scholar 

  21. Innovative Delivery Systems for Paediatric Medicines: Technology Landscape, World Health Organization, Geneva (2020).

    Google Scholar 

  22. V. Mogilyuk, Farm. Otrasl’, 3(50), 32 – 37 (2015).

    Google Scholar 

  23. GKF 2500 Capsule Filling Machine, https: //www.boschpackaging.com.

  24. K. M. Tserkovnaya, Yu. M. Kotsur, S. V. Okovityi, et al., Khim.-farm. Zh., 56(5), 3 – 9 (2022); Pharm. Chem. J., 56(5), 577 – 582 (2022).

  25. V. Tumuluri, Drug Delivery Trends, Vol. 3, Elsevier (2020).

  26. A. K. Saxena, A. Sharma, and N. Verma, Res. J. Pharm. Technol., 14(6), 3461 – 3470 (2021).

    Article  Google Scholar 

  27. M. Lengyel, N. Kallai-Szabo, V. Antal, et al., Sci. Pharm., 87(3), 20 (2019).

    Article  CAS  Google Scholar 

  28. R. Govender, S. Abrahmsen-Alami, S. Folestad, et al., Int. J. Pharm., 602 (2021).

  29. X.-Y. Chu, C.-H. Gao, C. Ge, and C.-S. Gao, Chin. J. New Drugs, 27(4), 409 – 416 (2018).

    Google Scholar 

  30. B. Mitra, J. Chang, S. J. Wu, et al., Int. J. Pharm., 525(1), 149 – 159 (2017).

    Article  CAS  PubMed  Google Scholar 

  31. H. P. Goh, P. W. S. Heng, and C. V. Liew, Int. J. Pharm., 534(1 – 2), 279 – 286 (2017).

    Article  CAS  PubMed  Google Scholar 

  32. K. Wening and J. Breitkreutz, Int. J. Pharm., 404(1 – 2), 1 – 9 (2011).

    Article  CAS  PubMed  Google Scholar 

  33. Smart Mini Tablet Dispenser (sMTS); https: //www.stevanatogroup.com/en/offering/plastic-solutions/pharmaceuticalproducts/smts/.

  34. K. Wening and J. Breitkreutz, Int. J. Pharm., 395(1 – 2), 174 – 181 (2010).

    Article  CAS  PubMed  Google Scholar 

  35. D. L. Kraft, US Pat. Appl. 11319125-B2, May 3, 2022; National Center for Biotechnology Information (2022).

  36. J. Tamargo, J. M. Castellano, and V. Fuster, Int. J. Cardiol., 201, 15 – 22 (2015).

    Article  Google Scholar 

  37. State Drug Registry; https: //grls.rosminzdrav.ru/.

  38. VIDAL, Handbook of Drugs; https: //www.vidal.ru/drugs/twynsta42599.

  39. Health Direct; https: //www.healthdirect.gov.au/medicines/brand/amt,33031000168101/twynsta-40-5-mg.

  40. D. Cimmaruta, N. Lombardi, C. Borghi, et al., Int. J. Cardiol., 252, 181 – 186 (2018).

    Article  CAS  PubMed  Google Scholar 

  41. B. Franczyk, A. Gluba-Brzozka, L. Jurkiewicz, et al., Expert Opin. Pharmacother., 19(17), 1857 – 1865 (2018).

    Article  CAS  PubMed  Google Scholar 

  42. C. K. Chow and Q. Meng, Nat. Rev. Cardiol., 16(10), 602 – 611 (2019).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. M. Tserkovnaya.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 1, pp. 43 – 51, January, 2023

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tserkovnaya, K.M., Kotsur, Y.M., Flisyuk, E.V. et al. Polypill as a Personalized Dosage Form: Production Technology (Review). Pharm Chem J 57, 108–115 (2023). https://doi.org/10.1007/s11094-023-02857-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-023-02857-6

Keywords

Navigation